kidney disease

With New Funding and CEO, This Southlake Biotech is Looking to Solve Kidney Disease

by | Feb 16, 2022
Renibus Therapeutics, which focuses on treatments for acute and chronic kidney diseases, announced closing a $35 million Series A funding round. Its new CEO, Frank Stonebanks, says "Renibus has arrived at a critical inflection point in its commitment to transform the prevention and treatment of kidney diseases."
MORE
research disease
Discovery: NASA Selects UTA Team to Examine ‘Space Weather,’ UTD Research Focuses on Chronic Pain
by | Jan 24, 2020
In this weekly roundup of research and development activity in North Texas, you'll also find out about a collaboration between the University of North Texas Health Science Center and Quest Diagnostics to address preventable diseases.
MORE